These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

646 related articles for article (PubMed ID: 25340915)

  • 41. Adalimumab for induction of remission in Crohn's disease.
    Abbass M; Cepek J; Parker CE; Nguyen TM; MacDonald JK; Feagan BG; Khanna R; Jairath V
    Cochrane Database Syst Rev; 2019 Nov; 2019(11):. PubMed ID: 31742665
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Celecoxib for rheumatoid arthritis.
    Fidahic M; Jelicic Kadic A; Radic M; Puljak L
    Cochrane Database Syst Rev; 2017 Jun; 6(6):CD012095. PubMed ID: 28597983
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Type I interferons for induction of remission in ulcerative colitis.
    Wang Y; MacDonald JK; Benchimol EI; Griffiths AM; Steinhart AH; Panaccione R; Seow CH
    Cochrane Database Syst Rev; 2015 Sep; 2015(9):CD006790. PubMed ID: 26368001
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Methotrexate for maintenance of remission in ulcerative colitis.
    Wang Y; MacDonald JK; Vandermeer B; Griffiths AM; El-Matary W
    Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD007560. PubMed ID: 26263042
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Rofecoxib for osteoarthritis.
    Garner SE; Fidan DD; Frankish R; Maxwell L
    Cochrane Database Syst Rev; 2005 Jan; 2005(1):CD005115. PubMed ID: 15654705
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A 6-week, multicentre, randomised, double-blind, double-dummy, active-controlled, clinical safety study of lumiracoxib and rofecoxib in osteoarthritis patients.
    Stricker K; Yu S; Krammer G
    BMC Musculoskelet Disord; 2008 Sep; 9():118. PubMed ID: 18778469
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis.
    Feagan BG; Macdonald JK
    Cochrane Database Syst Rev; 2012 Oct; 10():CD000543. PubMed ID: 23076889
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis.
    Wang Y; Parker CE; Bhanji T; Feagan BG; MacDonald JK
    Cochrane Database Syst Rev; 2016 Apr; 4(4):CD000543. PubMed ID: 27101467
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Interventions for fatigue in inflammatory bowel disease.
    Farrell D; Artom M; Czuber-Dochan W; Jelsness-Jørgensen LP; Norton C; Savage E
    Cochrane Database Syst Rev; 2020 Apr; 4(4):CD012005. PubMed ID: 32297974
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The impact of biological interventions for ulcerative colitis on health-related quality of life.
    LeBlanc K; Mosli MH; Parker CE; MacDonald JK
    Cochrane Database Syst Rev; 2015 Sep; 2015(9):CD008655. PubMed ID: 26393522
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Oral 5-aminosalicylic acid for maintenance of remission in ulcerative colitis.
    Wang Y; Parker CE; Feagan BG; MacDonald JK
    Cochrane Database Syst Rev; 2016 May; 2016(5):CD000544. PubMed ID: 27158764
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Single-dose intravenous diclofenac for acute postoperative pain in adults.
    McNicol ED; Ferguson MC; Schumann R
    Cochrane Database Syst Rev; 2018 Aug; 8(8):CD012498. PubMed ID: 30153336
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Methotrexate for induction of remission in refractory Crohn's disease.
    McDonald JW; Tsoulis DJ; Macdonald JK; Feagan BG
    Cochrane Database Syst Rev; 2012 Dec; 12():CD003459. PubMed ID: 23235598
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Celecoxib for osteoarthritis.
    Puljak L; Marin A; Vrdoljak D; Markotic F; Utrobicic A; Tugwell P
    Cochrane Database Syst Rev; 2017 May; 5(5):CD009865. PubMed ID: 28530031
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Rofecoxib for rheumatoid arthritis.
    Garner SE; Fidan DD; Frankish RR; Judd MG; Towheed TE; Wells G; Tugwell P
    Cochrane Database Syst Rev; 2005 Jan; 2005(1):CD003685. PubMed ID: 15674912
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Vitamin D for the treatment of inflammatory bowel disease.
    Wallace C; Gordon M; Sinopoulou V; Limketkai BN
    Cochrane Database Syst Rev; 2023 Oct; 10(10):CD011806. PubMed ID: 37781953
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Oral 5-aminosalicylic acid for maintenance of remission in ulcerative colitis.
    Feagan BG; Macdonald JK
    Cochrane Database Syst Rev; 2012 Oct; 10():CD000544. PubMed ID: 23076890
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Azathioprine and 6-mercaptopurine for maintenance of surgically-induced remission in Crohn's disease.
    Gjuladin-Hellon T; Iheozor-Ejiofor Z; Gordon M; Akobeng AK
    Cochrane Database Syst Rev; 2019 Aug; 8(8):CD010233. PubMed ID: 31425621
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Incidence and possible risk factors for clinical upper gastrointestinal events in patients taking selective cyclooxygenase-2 inhibitors: A prospective, observational, cohort study in Taiwan.
    Hsiang KW; Chen TS; Lin HY; Luo JC; Lu CL; Lin HC; Lee KC; Chang FY; Lee SD
    Clin Ther; 2010 Jul; 32(7):1294-303. PubMed ID: 20678677
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Safety of selective cyclooxygenase-2 inhibitors in inflammatory bowel disease.
    Mahadevan U; Loftus EV; Tremaine WJ; Sandborn WJ
    Am J Gastroenterol; 2002 Apr; 97(4):910-4. PubMed ID: 12008668
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.